Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raj Sengupta

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Arthritis Research & Therapy|September 23, 2017
Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative studyDeepak R Jadon, Raj Sengupta, Alison Nightingale, et al.
Annals of the Rheumatic Diseases|December 4, 2016
Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritisDeepak R Jadon, Raj Sengupta, Alison Nightingale, et al.
Seminars in Arthritis and Rheumatism|November 13, 2018
Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) meetingSonya Abraham, Anne Barton, Lihi Eder, et al.
Rheumatology Advances in Practice|August 21, 2024
British Axial Spondyloarthritis Inception Cohort (BAxSIC): a protocol for a multicentre real-world observational cohort study of early axial spondyloarthritisJake Weddell, Stephanie R Harrison, Alexander N Bennett, et al.
Rheumatology (Oxford, England)|July 28, 2018
Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national registerGary J Macfarlane, Ross I R MacDonald, Ejaz Pathan, et al.
Chinese Medical Journal|September 14, 2020
Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5Feng Huang, Fei Sun, Wei-Guo Wan, et al.
Rheumatology and Therapy|June 2, 2026
Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III TrialsRaj Sengupta, Pedro M Machado, Philippe Goupille, et al.
Arthritis Care & Research|June 13, 2025
Non-steroidal anti-inflammatory drugs reduce sacroiliac joint inflammation, as seen on MRI, in axial spondyloarthritisGareth T Jones, Alexander N Bennett, Raj Sengupta, et al.
Rheumatology Advances in Practice|July 5, 2021
Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritisRebecca Pedley, Linda E Dean, Ernest Choy, et al.
Rheumatology (Oxford, England)|August 26, 2016
BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologicsLouise Hamilton, Nick Barkham, Ashok Bhalla, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Arthritis Research & Therapy|September 23, 2017
Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative studyDeepak R Jadon, Raj Sengupta, Alison Nightingale, et al.
Annals of the Rheumatic Diseases|December 4, 2016
Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritisDeepak R Jadon, Raj Sengupta, Alison Nightingale, et al.
Seminars in Arthritis and Rheumatism|November 13, 2018
Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) meetingSonya Abraham, Anne Barton, Lihi Eder, et al.
Rheumatology Advances in Practice|August 21, 2024
British Axial Spondyloarthritis Inception Cohort (BAxSIC): a protocol for a multicentre real-world observational cohort study of early axial spondyloarthritisJake Weddell, Stephanie R Harrison, Alexander N Bennett, et al.
Rheumatology (Oxford, England)|July 28, 2018
Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national registerGary J Macfarlane, Ross I R MacDonald, Ejaz Pathan, et al.
Chinese Medical Journal|September 14, 2020
Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase III China-centric study, MEASURE 5Feng Huang, Fei Sun, Wei-Guo Wan, et al.
Rheumatology and Therapy|June 2, 2026
Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III TrialsRaj Sengupta, Pedro M Machado, Philippe Goupille, et al.
Arthritis Care & Research|June 13, 2025
Non-steroidal anti-inflammatory drugs reduce sacroiliac joint inflammation, as seen on MRI, in axial spondyloarthritisGareth T Jones, Alexander N Bennett, Raj Sengupta, et al.
Rheumatology Advances in Practice|July 5, 2021
Feasibility, acceptability and change in health following a telephone-based cognitive behaviour therapy intervention for patients with axial spondyloarthritisRebecca Pedley, Linda E Dean, Ernest Choy, et al.
Rheumatology (Oxford, England)|August 26, 2016
BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologicsLouise Hamilton, Nick Barkham, Ashok Bhalla, et al.
Pageof 9